Literature DB >> 22159091

The role of gap junctions in Charcot-Marie-Tooth disease.

Kleopas A Kleopa1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 22159091      PMCID： PMC6634164          DOI： 10.1523/JNEUROSCI.4824-11.2011

Source DB:  PubMed          Journal:  J Neurosci        ISSN： 0270-6474            Impact factor:   6.167


× No keyword cloud information.
  111 in total

1.  Central nervous system involvement in a novel connexin 32 mutation affecting identical twins.

Authors:  W Marques; J G Sweeney; N W Wood; S J Wroe; W Marques
Journal:  J Neurol Neurosurg Psychiatry       Date:  1999-06       Impact factor: 10.154

Review 2.  Genetic diseases and gene knockouts reveal diverse connexin functions.

Authors:  T W White; D L Paul
Journal:  Annu Rev Physiol       Date:  1999       Impact factor: 19.318

3.  Three-dimensional structure of a recombinant gap junction membrane channel.

Authors:  V M Unger; N M Kumar; N B Gilula; M Yeager
Journal:  Science       Date:  1999-02-19       Impact factor: 47.728

Review 4.  The role of the gap junction protein connexin32 in the pathogenesis of X-linked Charcot-Marie-Tooth disease.

Authors:  S S Scherer; L J Bone; S M Deschênes; A Abel; R J Balice-Gordon; K H Fischbeck
Journal:  Novartis Found Symp       Date:  1999

5.  Genotype/phenotype correlations in X-linked dominant Charcot-Marie-Tooth disease.

Authors:  A F Hahn; C F Bolton; C M White; W F Brown; S E Tuuha; C C Tan; P J Ainsworth
Journal:  Ann N Y Acad Sci       Date:  1999-09-14       Impact factor: 5.691

6.  Distal axonopathy in peripheral nerves of PMP22-mutant mice.

Authors:  S Sancho; J P Magyar; A Aguzzi; U Suter1
Journal:  Brain       Date:  1999-08       Impact factor: 13.501

7.  Altered formation of hemichannels and gap junction channels caused by C-terminal connexin-32 mutations.

Authors:  C Castro; J M Gómez-Hernandez; K Silander; L C Barrio
Journal:  J Neurosci       Date:  1999-05-15       Impact factor: 6.167

8.  X-linked dominant Charcot-Marie-Tooth neuropathy: clinical, electrophysiological, and morphological phenotype in four families with different connexin32 mutations(1).

Authors:  J Senderek; B Hermanns; C Bergmann; B Boroojerdi; M Bajbouj; M Hungs; V T Ramaekers; S Quasthoff; D Karch; J M Schröder
Journal:  J Neurol Sci       Date:  1999-08-15       Impact factor: 3.181

9.  Studies in transgenic mice indicate a loss of connexin32 function in X-linked Charcot-Marie-Tooth disease.

Authors:  A Abel; L J Bone; A Messing; S S Scherer; K H Fischbeck
Journal:  J Neuropathol Exp Neurol       Date:  1999-07       Impact factor: 3.685

10.  Demyelinating X-linked Charcot-Marie-Tooth disease: unusual electrophysiological findings.

Authors:  F Tabaraud; E Lagrange; P Sindou; A Vandenberghe; N Levy; J M Vallat
Journal:  Muscle Nerve       Date:  1999-10       Impact factor: 3.217
View more
  11 in total

Review 1.  Brain connexins in demyelinating diseases: therapeutic potential of glial targets.

Authors:  Maria Luisa Cotrina; Maiken Nedergaard
Journal:  Brain Res       Date:  2012-07-10       Impact factor: 3.252

Review 2.  Connexins-mediated glia networking impacts myelination and remyelination in the central nervous system.

Authors:  Tao Li; Christian Giaume; Lan Xiao
Journal:  Mol Neurobiol       Date:  2014-01-07       Impact factor: 5.590

Review 3.  Heterogeneity in oligodendroglia: Is it relevant to mouse models and human disease?

Authors:  Isis M Ornelas; Lauren E McLane; Aminat Saliu; Angelina V Evangelou; Luipa Khandker; Teresa L Wood
Journal:  J Neurosci Res       Date:  2016-08-25       Impact factor: 4.164

Review 4.  Dysregulation of ErbB Receptor Trafficking and Signaling in Demyelinating Charcot-Marie-Tooth Disease.

Authors:  Samuel M Lee; Lih-Shen Chin; Lian Li
Journal:  Mol Neurobiol       Date:  2016-01-05       Impact factor: 5.590

5.  Intrathecal gene therapy rescues a model of demyelinating peripheral neuropathy.

Authors:  Alexia Kagiava; Irene Sargiannidou; George Theophilidis; Christos Karaiskos; Jan Richter; Stavros Bashiardes; Natasa Schiza; Marianna Nearchou; Christina Christodoulou; Steven S Scherer; Kleopas A Kleopa
Journal:  Proc Natl Acad Sci U S A       Date:  2016-03-28       Impact factor: 11.205

6.  Systemic inflammation disrupts oligodendrocyte gap junctions and induces ER stress in a model of CNS manifestations of X-linked Charcot-Marie-Tooth disease.

Authors:  Margarita Olympiou; Irene Sargiannidou; Kyriaki Markoullis; Christos Karaiskos; Alexia Kagiava; Styliana Kyriakoudi; Charles K Abrams; Kleopas A Kleopa
Journal:  Acta Neuropathol Commun       Date:  2016-09-01       Impact factor: 7.801

7.  The role of oligodendrocyte gap junctions in neuroinflammation.

Authors:  Christos Papaneophytou; Elena Georgiou; Kleopas A Kleopa
Journal:  Channels (Austin)       Date:  2019-12       Impact factor: 2.581

Review 8.  Gap Junctions in the Nervous System: Probing Functional Connections Using New Imaging Approaches.

Authors:  Ao Dong; Simin Liu; Yulong Li
Journal:  Front Cell Neurosci       Date:  2018-09-19       Impact factor: 5.505

Review 9.  What's the Function of Connexin 32 in the Peripheral Nervous System?

Authors:  Mario Bortolozzi
Journal:  Front Mol Neurosci       Date:  2018-07-10       Impact factor: 5.639

10.  Dysregulation of Blood-Brain Barrier and Exacerbated Inflammatory Response in Cx47-Deficient Mice after Induction of EAE.

Authors:  Filippos Stavropoulos; Elena Georgiou; Irene Sargiannidou; Kleopas A Kleopa
Journal:  Pharmaceuticals (Basel)       Date:  2021-06-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.